 |
| Home |
| Political News |
| Meet Your Local MP |
| Comment |
| Have Your Say |
| Campaigns |
| Theresa May |
| John Redwood |
| Martin Salter |
| Rob Wilson |
| Richard Benyon |
| Useful Links |
- AAT Courses
- Absolute Health and Safety Solutions Limited
- Business lead generation
- Customer testimonials
- Diamond drilling
- First page seo
- Information Drivers
- Kids in Berkshire
- LIVE answering service
- Mary Flavelle
- NRG Networks
- On this day in history
- Outbound telemarketing services
- Personal business coach
- Positive energy
- Promotional micro sites
- Sales force outsourcing
- Sales training consultancy
- Technical Concrete Cutting Limited
- Windsor Vehicle Leasing
|
Wilson calls for speedy decision on Lucentis
|
Rob Wilson, Member of Parliament for Reading East, today took part in a Westminster Hall Debate, secured by The Rt Hon Sir George Young, to highlight the ongoing problems that local people are having with getting the latest ground-breaking drugs prescribed by PCTs for Wet Age-Related Macular Degeneration (AMD).
Rob Wilson said: "I know the Health Service and local PCTs have very difficult financial judgements to make about new drugs that come on to the market but both Lucentis and Macugen have been approved and are free for doctors to prescribe if PCTs will let them. We know that both these drugs have a positive effect on Wet AMD. It is not morally acceptable to allow somebody to go blind when we know drugs exist that will stop that process." Rob raised the case of 79-year-old Les Dean, previously highlighted by the Reading Evening Post, who was forced to spend £6,000 or go blind in a matter of weeks. Wet AMD can cause blindness in as little as three weeks from its first detection. He said: "While PCTs make up their minds about prescribing these drugs, people are going blind. Does the Minister not agree this is reprehensible? Is it not morally wrong to force a pensioner to choose between blindness and life-savings." Berkshire West PCT has recently written to Mr Wilson confirming it will make a decision in May, but will offer a course of treatment to 16 patients - although it did not say whether this treatment would be with the new drugs. 17/04/07 |
|
Wordtracker |
|
|
